Galectin Therapeutics (GALT) Other Accumulated Expenses (2011 - 2026)
Galectin Therapeutics (GALT) recorded Other Accumulated Expenses of $6,000 in Q3 2015, up 200.0% from $2,000 a year earlier but down 14.3% from the prior quarter.
Powered by 
Analysis
Galectin Therapeutics (GALT) Other Accumulated Expenses (2011 - 2026) Analysis & Trends
At the end of FY2014, Galectin Therapeutics reported Other Accumulated Expenses of $7,000, down 68.2% from FY2013.
- Annual Other Accumulated Expenses has a three-year compound annual growth rate of -58.4% (FY2011 to FY2014).
- Across earlier years, Other Accumulated Expenses came in at $22,000 in FY2013 (+120.0%), $10,000 in FY2012 (-89.7%) and $97,000 in FY2011.
- Quarterly Other Accumulated Expenses has ranged from $2,000 in Q2 2014 to $98,000 in Q1 2014 over the past five years.
- On a year-over-year basis, Other Accumulated Expenses rose in four of the last eight quarters, with growth averaging 136.2%.
- Peak year-over-year performance for Other Accumulated Expenses in the last five years was growth of 790.9% in Q1 2014, against a decline of 96.3% in Q3 2014 at the low end.
- Per Business Quant, the preceding three quarters came in at $7,000 (Q2 2015), $72,000 (Q1 2015) and $7,000 (Q4 2014).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Galectin Therapeutics | 224.13 Mn | 167.48 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 167,000.00 |
| Mar 31, 2026 | 68,000.00 |
| Dec 31, 2025 | 96,000.00 |
| Dec 31, 2024 | 243,000.00 |
| Dec 31, 2023 | 490,000.00 |
| Dec 31, 2022 | 733,000.00 |
| Dec 31, 2021 | 7,000.00 |
| Dec 31, 2020 | 135,000.00 |
| Dec 31, 2019 | 258,000.00 |
| Sep 30, 2019 | 287,000.00 |
| Jun 30, 2019 | 317,000.00 |
| Mar 31, 2019 | 347,000.00 |
| Dec 31, 2018 | 174,000.00 |
| Sep 30, 2018 | 86,000.00 |
| Jun 30, 2018 | 172,000.00 |
| Mar 31, 2018 | 258,000.00 |
| Dec 31, 2017 | 342,000.00 |
| Sep 30, 2015 | 6,000.00 |
| Jun 30, 2015 | 7,000.00 |
| Mar 31, 2015 | 72,000.00 |
API Access
Galectin Therapeutics Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=GALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "GALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=GALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();